Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Neuroendocrine | 5 | 2022 | 332 | 1.020 |
Why?
|
Tandem Repeat Sequences | 2 | 2021 | 185 | 0.870 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 222 | 0.800 |
Why?
|
Leukemia, Myeloid, Acute | 6 | 2023 | 3523 | 0.790 |
Why?
|
fms-Like Tyrosine Kinase 3 | 3 | 2023 | 491 | 0.710 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 294 | 0.700 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 670 | 0.620 |
Why?
|
Prostatic Neoplasms | 13 | 2022 | 11124 | 0.610 |
Why?
|
Carcinoma, Small Cell | 2 | 2019 | 420 | 0.590 |
Why?
|
Myelodysplastic Syndromes | 2 | 2023 | 1352 | 0.530 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2020 | 388 | 0.520 |
Why?
|
Repressor Proteins | 3 | 2021 | 3023 | 0.510 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 719 | 0.510 |
Why?
|
Hematologic Neoplasms | 2 | 2023 | 1832 | 0.510 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3597 | 0.460 |
Why?
|
Cyclin D1 | 1 | 2015 | 463 | 0.450 |
Why?
|
Medical Informatics | 1 | 2020 | 745 | 0.440 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2023 | 1519 | 0.330 |
Why?
|
Exons | 3 | 2023 | 2437 | 0.300 |
Why?
|
Kidney Neoplasms | 4 | 2023 | 4262 | 0.260 |
Why?
|
Transcription Factors | 2 | 2023 | 12208 | 0.240 |
Why?
|
Sequence Analysis, RNA | 2 | 2023 | 2012 | 0.240 |
Why?
|
Neuroendocrine Tumors | 2 | 2022 | 594 | 0.240 |
Why?
|
Gene Duplication | 2 | 2022 | 329 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2023 | 318 | 0.220 |
Why?
|
Adenocarcinoma | 3 | 2019 | 6364 | 0.210 |
Why?
|
Adenoma, Oxyphilic | 1 | 2023 | 143 | 0.200 |
Why?
|
Leiomyomatosis | 1 | 2022 | 70 | 0.200 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2021 | 45 | 0.200 |
Why?
|
Kidney Medulla | 1 | 2021 | 182 | 0.190 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 1 | 2022 | 105 | 0.190 |
Why?
|
Sarcoma, Clear Cell | 1 | 2021 | 76 | 0.190 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2023 | 1581 | 0.190 |
Why?
|
Alleles | 2 | 2022 | 6933 | 0.180 |
Why?
|
Algorithms | 1 | 2020 | 13881 | 0.180 |
Why?
|
Philadelphia Chromosome | 1 | 2020 | 112 | 0.170 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 407 | 0.170 |
Why?
|
Protein Isoforms | 1 | 2023 | 1730 | 0.160 |
Why?
|
Translocation, Genetic | 1 | 2023 | 1420 | 0.160 |
Why?
|
Neoplasm Metastasis | 6 | 2019 | 4851 | 0.160 |
Why?
|
Crystallins | 1 | 2017 | 75 | 0.150 |
Why?
|
Thoracic Neoplasms | 1 | 2020 | 268 | 0.150 |
Why?
|
Carcinoma, Renal Cell | 2 | 2023 | 3143 | 0.150 |
Why?
|
Myeloproliferative Disorders | 1 | 2023 | 606 | 0.150 |
Why?
|
Gene Fusion | 1 | 2019 | 371 | 0.140 |
Why?
|
Neoplasms | 2 | 2023 | 21683 | 0.140 |
Why?
|
Testicular Neoplasms | 1 | 2022 | 804 | 0.140 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14722 | 0.140 |
Why?
|
Staining and Labeling | 1 | 2020 | 1100 | 0.130 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13102 | 0.130 |
Why?
|
Immunohistochemistry | 3 | 2022 | 11366 | 0.130 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5442 | 0.130 |
Why?
|
Neuroendocrine Cells | 1 | 2015 | 61 | 0.120 |
Why?
|
Humans | 36 | 2023 | 744343 | 0.120 |
Why?
|
Germ-Line Mutation | 1 | 2022 | 1788 | 0.120 |
Why?
|
Genetic Heterogeneity | 1 | 2017 | 733 | 0.120 |
Why?
|
Gene Expression Profiling | 4 | 2019 | 9438 | 0.120 |
Why?
|
Gene Frequency | 1 | 2020 | 3588 | 0.110 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 1344 | 0.110 |
Why?
|
Brain Neoplasms | 3 | 2022 | 8863 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 705 | 0.100 |
Why?
|
RNA | 1 | 2022 | 2749 | 0.100 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1950 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1363 | 0.100 |
Why?
|
Retinoblastoma Protein | 1 | 2015 | 704 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6538 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2023 | 12959 | 0.100 |
Why?
|
Databases, Genetic | 1 | 2017 | 1783 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4186 | 0.090 |
Why?
|
Computational Biology | 3 | 2017 | 3521 | 0.090 |
Why?
|
Receptors, Androgen | 1 | 2016 | 1058 | 0.090 |
Why?
|
Male | 20 | 2022 | 350118 | 0.090 |
Why?
|
Actins | 1 | 2017 | 2121 | 0.090 |
Why?
|
Genomics | 2 | 2023 | 5720 | 0.090 |
Why?
|
Neoplastic Syndromes, Hereditary | 2 | 2022 | 241 | 0.090 |
Why?
|
Androgen Antagonists | 1 | 2018 | 1377 | 0.090 |
Why?
|
Mutation | 6 | 2023 | 29786 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4554 | 0.080 |
Why?
|
DNA-Binding Proteins | 2 | 2023 | 9648 | 0.080 |
Why?
|
Gene Expression | 3 | 2016 | 7799 | 0.080 |
Why?
|
Cell Movement | 2 | 2017 | 5217 | 0.080 |
Why?
|
Prognosis | 5 | 2023 | 29063 | 0.080 |
Why?
|
Glioma | 1 | 2022 | 3401 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 8428 | 0.080 |
Why?
|
Prostate | 3 | 2022 | 1774 | 0.070 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5686 | 0.070 |
Why?
|
Drosophila | 1 | 2014 | 1491 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2282 | 0.070 |
Why?
|
Oncogenes | 2 | 2022 | 1265 | 0.070 |
Why?
|
Disease Progression | 1 | 2022 | 13284 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3703 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3505 | 0.060 |
Why?
|
Germ Cells | 2 | 2022 | 631 | 0.060 |
Why?
|
Child | 5 | 2023 | 77709 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2022 | 2649 | 0.060 |
Why?
|
Neoplasm, Residual | 2 | 2022 | 973 | 0.060 |
Why?
|
Transplantation, Homologous | 2 | 2023 | 4776 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9239 | 0.060 |
Why?
|
Mice | 7 | 2023 | 81183 | 0.060 |
Why?
|
Bone Marrow | 2 | 2023 | 2948 | 0.060 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2019 | 602 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6773 | 0.050 |
Why?
|
Fumarate Hydratase | 1 | 2022 | 47 | 0.050 |
Why?
|
Sequence Analysis | 1 | 2022 | 256 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 200 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 379 | 0.050 |
Why?
|
Animals | 9 | 2023 | 168757 | 0.050 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2022 | 165 | 0.050 |
Why?
|
Hematoxylin | 1 | 2020 | 64 | 0.050 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2020 | 72 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2017 | 7880 | 0.050 |
Why?
|
Cohort Studies | 2 | 2020 | 40561 | 0.050 |
Why?
|
Recurrence | 2 | 2022 | 8340 | 0.050 |
Why?
|
Proteins | 1 | 2015 | 6103 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2016 | 18029 | 0.040 |
Why?
|
Codon | 1 | 2021 | 611 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 426 | 0.040 |
Why?
|
Genetic Variation | 1 | 2014 | 6544 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2018 | 3557 | 0.040 |
Why?
|
Microsatellite Instability | 1 | 2022 | 684 | 0.040 |
Why?
|
Seminal Vesicles | 1 | 2018 | 101 | 0.040 |
Why?
|
Calcitonin | 1 | 2019 | 336 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3752 | 0.040 |
Why?
|
Aged | 5 | 2023 | 163280 | 0.040 |
Why?
|
Carbazoles | 1 | 2019 | 226 | 0.040 |
Why?
|
Base Sequence | 2 | 2022 | 12797 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2021 | 16689 | 0.040 |
Why?
|
Cell Transdifferentiation | 1 | 2018 | 172 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2022 | 1086 | 0.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1660 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2017 | 712 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2022 | 1598 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2109 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2019 | 1364 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2022 | 1513 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2023 | 2725 | 0.030 |
Why?
|
Phenotype | 2 | 2021 | 16365 | 0.030 |
Why?
|
Middle Aged | 3 | 2023 | 213383 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2014 | 528 | 0.030 |
Why?
|
Cell Line | 2 | 2017 | 15997 | 0.020 |
Why?
|
Piperidines | 1 | 2019 | 1602 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1094 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2014 | 913 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2017 | 2699 | 0.020 |
Why?
|
Mice, SCID | 1 | 2015 | 2716 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1157 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2014 | 2256 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3479 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 1972 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6114 | 0.020 |
Why?
|
Prostatectomy | 1 | 2018 | 1890 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3616 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2017 | 2382 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5853 | 0.020 |
Why?
|
RNA Interference | 1 | 2017 | 2889 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2018 | 2494 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4204 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4286 | 0.020 |
Why?
|
Cell Division | 1 | 2015 | 4568 | 0.020 |
Why?
|
Pyrimidines | 1 | 2020 | 2942 | 0.020 |
Why?
|
Female | 3 | 2022 | 380194 | 0.020 |
Why?
|
Cell Cycle | 1 | 2015 | 2967 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4445 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 53288 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5535 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1903 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5078 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6171 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10180 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10481 | 0.020 |
Why?
|
Protein Binding | 1 | 2017 | 9386 | 0.020 |
Why?
|
Genetic Loci | 1 | 2014 | 2575 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6756 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15076 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18111 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 77449 | 0.010 |
Why?
|
Infant | 1 | 2021 | 35136 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 41006 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13695 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 63114 | 0.010 |
Why?
|
Adult | 1 | 2020 | 214055 | 0.000 |
Why?
|
Concepts
(182)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(101)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_